RESULTS OF ABBREVIATED MAGNETIC RESONANCE IMAGING (AMRI) COMPARED WITH MAGNETIC RESONANCE IMAGING (MRI) ON 92 LESIONS WITH SUSPICIOUS BREAST CANCER AT K HOSPITAL
Main Article Content
Abstract
Objective: To evaluate the role of the 1.5 Tesla Abbreviated Magnetic Resonance Imaging (AMRI) in the diagnosis the lessions of breast cancer. Subjects and methods: The retrospective study was conducted at K Hospital from June 2020 to June 2022, on 92 lessions with suspicious breast cancer, undergoing 1.5 Tesla MRI with 02 protocols: full and abbreviated protocol (integrated), with histopathological results after needle biopsy and/or surgery. The abbreviated protocol performed in the study included axial STIR and axial T1FS sequences before injection, 1 minute, and 2 minutes after injection. MRI images were classified into 2 groups: full and abbreviated protocol, encrypted and blinded patient information. Results were independently evaluated by two experienced radiologists. The imaging, pathologic features, and value of the two methods were analyzed. Results: With 92 suspicious lesions of the breast cancer were detected in 82 patients , of which 51 cases were cancer and 41 cases were benign lesions. The lesion detection rate of the abbreviated MRI(AB-MRI) compared with full diagnostic MRI(FD-MRI) was 97.8%. There are Two cases were not observed on AMRI, accounting for 2.2%, classified as BI-RADS 3 on MRI, and were benign lesions. On the other hand, comparing the ability to classify breast lesions according to BI-RADS on the MRI with MRI, the agreement was very good (Cohen’s Kappa index=0.866). The accuracy, sensitivity, and specificity of AMRI (BIRADS≥4) in the diagnosis of breast cancer were 81.5%, 100%, and 55.8%, respectively. Conclusion: Abbreviated MRI is a precious method in the diagnosis of breast cancer, with sensitivity and accuracy equivalent to full diagnostic MRI.
Article Details
Keywords
Abbreviated Magnetic resonance imaging, Magnetic resonance imaging, breast cancer.
References
![](https://tapchiyhocvietnam.vn/templates/images/icons/gscholar.png)
2. Mainiero MB, Moy L, Baron P, et al (2017). ACR Appropriateness Criteria((R)) Breast Cancer Screening. J Am Coll Radiol, 14(11S):S383-S390.
![](https://tapchiyhocvietnam.vn/templates/images/icons/gscholar.png)
3. Mann RM, van Zelst JCM, Vreemann S, Mus RDM (2019). Is Ultrafast or Abbreviated Breast MRI Ready for Prime Time? Current Breast Cancer Reports, 11(1):9-16.
![](https://tapchiyhocvietnam.vn/templates/images/icons/gscholar.png)
4. Moschetta M, Telegrafo M, Rella L, Stabile Ianora AA, Angelelli G (2016). Abbreviated Combined MR Protocol: A New Faster Strategy for Characterizing Breast Lesions. Clin Breast Cancer, 16(3):207-11.
![](https://tapchiyhocvietnam.vn/templates/images/icons/gscholar.png)
5. Kuhl CK, Schrading S, Strobel K, Schild HH, Hilgers RD, Bieling HB (2014). Abbreviated breast magnetic resonance imaging (MRI): first postcontrast subtracted images and maximum-intensity projection-a novel approach to breast cancer screening with MRI. J Clin Oncol, 32(22):2304-10.
![](https://tapchiyhocvietnam.vn/templates/images/icons/gscholar.png)
6. Lee-Felker S, Joines M, Storer L, et al (2019). Abbreviated Breast MRI for Estimating Extent of Disease in Newly Diagnosed Breast Cancer. Journal of Breast Imaging, 2(1):43-49.
![](https://tapchiyhocvietnam.vn/templates/images/icons/gscholar.png)
7. Mann RM, Cho N, Moy L (2019). Breast MRI: State of the Art. Radiology, 292(3):520-536.
![](https://tapchiyhocvietnam.vn/templates/images/icons/gscholar.png)